These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 2622598)

  • 1. [Characteristics of the immune status of patients with uveal melanoma during the performance of organ-preserving treatment].
    Maletskiĭ AP; Vit VV; Vanichkin AA
    Oftalmol Zh; 1989; (6):341-6. PubMed ID: 2622598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoglobulins M, G and A as prognostic criteria of the treatment outcome in uveal melanoblastoma].
    Kotelianskiĭ EO
    Oftalmol Zh; 1989; (2):104-7. PubMed ID: 2755651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of a melanoma of the choroid or ciliary body].
    de Jong PT
    Ned Tijdschr Geneeskd; 1987 Mar; 131(11):439-43. PubMed ID: 3561548
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How should melanoma of the choroid or ciliary body be managed?].
    Manschot WA
    Ned Tijdschr Geneeskd; 1987 Mar; 131(12):504-5. PubMed ID: 3574504
    [No Abstract]   [Full Text] [Related]  

  • 6. [How should melanoma of the choroid or ciliary body be managed?].
    Steggerda NF
    Ned Tijdschr Geneeskd; 1987 Jun; 131(26):1144. PubMed ID: 3614397
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to proceed in a case of choroid or ciliary body melanoma?].
    Ned Tijdschr Geneeskd; 1987 May; 131(18):780-1. PubMed ID: 3587407
    [No Abstract]   [Full Text] [Related]  

  • 8. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
    Jager MJ; Ly LV; El Filali M; Madigan MC
    Prog Retin Eye Res; 2011 Mar; 30(2):129-46. PubMed ID: 21129496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of intraocular melanoma: new concepts].
    De Potter P
    Bull Mem Acad R Med Belg; 2003; 158(1-2):103-11; discussion 111-2. PubMed ID: 12852096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of eyeball and ocular appendages malignant tumors].
    Iunusova GD
    Vestn Oftalmol; 1999; 115(4):37-8. PubMed ID: 10523967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the lymphocyte blast transformation reaction as a criterion of prognosis in the outcome of treatment of uveal melanoblastomas].
    Kotelianskiĭ EO
    Oftalmol Zh; 1986; (7):407-9. PubMed ID: 3493458
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological aspects of malignant melanomas of the choroid].
    Le Hoang P
    Bull Soc Ophtalmol Fr; 1986 Nov; Spec No():143-51. PubMed ID: 3791545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conservative treatment of intraocular tumors in the adult].
    Zografos L; Gailloud C
    Ther Umsch; 1984 Apr; 41(4):278-80. PubMed ID: 6729760
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
    Augsburger JJ; Corrêa ZM; Freire J; Brady LW
    Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brachytherapy in choroidal melanoma].
    Starzycka M; Słomska J; Romanowska B
    Klin Oczna; 1999; 101(1):19-22. PubMed ID: 10401209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What to think of "adjuvant" or "neoadjuvant" thermotherapy in the treatment of uveal melanomas?].
    Grange JD
    J Fr Ophtalmol; 2001 Feb; 24(2):191-8. PubMed ID: 11240495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.